2022 International Congress » Parkinson's Disease: Non-Motor Symptoms

A prospective, controlled study of subthalamic stimulation in Parkinson’s disease: quality of life outcome at the 5-year follow-up

S. Jost, S. Aloui, A. Rizos, K. Ashkan, J. Evans, A. Sauerbier, J. Petry-Schmelzer, A. Gronostay, G. Fink, M. Barbe, V. Visser-Vandewalle, A. Antonini, M. Silverdale, P. Martinez-Martin, L. Timmermann, K. Ray Chaudhuri, H. Dafsari (Cologne, Germany)

Action verb use in PD: A challenge to the embodied cognition hypothesis?

E. Nascimento Andrade, C. Manxhari, K. Smith (Worcester, USA)

Anthropometric Changes in Parkinson’s Disease: Canadian Longitudinal Study on Aging

S. Zolfaghari, A. Pelletier, R. Postuma (Montreal, Canada)

Asymmetry of Motor and Non-motor Signs in Parkinson’s Disease: An Exploratory Clinical Case-control Study

F. Hansen, N. Okkels, P. Borghammer (Aarhus N, Denmark)

Autonomic dysfunction and its correlation witn synucleinopathy: an immunohistological study in Tunisian patients with parkinson disease

N. Ben Ali, L. Ali, S. Fezai, H. Jamoussi, S. Fray, M. Ben Mahmoud, M. Fredj (Tunis, Tunisia)

Autonomic dysfunction in p.A53T SNCA PD vs GBA PD and idiopathic PD : A study in a Greek population.

AM. Simitsi, P. Kokotis, C. Koros, C. Bougea, N. Papagiannakis, R. Antonelou, I. Pachi, D. Papadimitrioy, M. Stamelou, L. Stefanis (ATHENS, Greece)

Autonomic Nervous System Dysfunction in idiopathic REM sleep behaviour disorder

Y. Shao, T. Wijratne (Melbourne, Australia)

Blood biomarkers and their association with non-motor symptoms in early Parkinson’s Disease

J. Kaur, S. Ng, N. Chia, X. Deng, J. Tan, X. Choi, D. Heng, Z. Xu, K. Tay, W. Au, A. Ng, E. Tan, L. Tan (central, Singapore)

Caregiver burden in Parkinson’s Disease patients with Cardiovascular Dysautonomia

C. Ledda, G. Imbalzano, C. Artusi, A. Merola, E. Montanaro, M. Zibetti, M. Rizzone, G. Sobrero, F. Vallelonga, S. Maule, L. Lopiano, A. Romagnolo (Turin, Italy)

Central fatigue and glutamatergic overactivity in Parkinson’s disease: possible impact of safinamide

C. Pauletti, N. Locuratolo, D. Mannarelli, A. Maffucci, A. Petritis, F. Fattapposta (Rome, Italy)

Characteristics of Fatigue and Correlation with the Symptoms of Parkinson’s Disease

XJ. Huang, Y. Qu, JT. Li, YP. Chen, JY. Li, QX. Qin, DL. Wang, JW. Zhao, ZJ. Mao, YJ. Xiong, Z. Min, Z. Xue (Wuhan, China)

Characterization of gastrointestinal dysfunction in Parkinson’s by disease stage

M. Camacho, J. Greenland, D. Apostolopoulos, C. Daruwalla, C. Williams-Gray (Cambridge, United Kingdom)

Characterization of nociplastic pains in Parkinson’s disease (PD) with the PD pain classification system (PD-PCS)

V. Mylius, S. Lloret, N. Fisch, R. Gonzenbach, G. Kägi, J. Möller, F. Brugger, D. de Andrade (Valens, Switzerland)

Chronic Visceral Pain in Parkinson’s Disease and Link with White Matter Hyperintensities

K. Rukavina, J. Staunton, M. Krbot Skoric, S. Rota, A. Rizos, K. Ray Chaudhuri (London, United Kingdom)

Cognitive and Motor aspects of a Brazilian population with Parkinson´s disease and Impulse Control Disorders and/or Related Behaviors – an observational study.

B. Veiga, C. da Silva, L. Barcelos, H. Ferraz, S. Silva, V. Borges (São Paulo, Brazil)

Color vision deficits in Parkinson’s disease are linked to brain abnormalities in attentional, fronto-pariental and visual networks

M. Diez-Cirarda, A. Murueta-Goyena, A. Miscioscia, R. Del Pino, S. Teijeira, MA. Acera, O. Lucas-Jimenez, N. Ojeda, B. Tijero, JC. Gomez-Esteban, I. Gabilondo (Barakaldo, Spain)

Comparison of Disease Progression in Patients with Brain-first versus Body-first Parkinson’s Disease

DW. Ryu, SW. Yoo, KS. Lee, SG. Ha, JS. Kim (Seoul, Republic of Korea)

Correlation between cognitive impairment and neuropsychiatric symptoms in Mexican persons living with Parkinson’s disease.

GI. Cerda-Hernández, AJ. Hernández-Medrano, P. Bazán-Rodríguez, E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, MA. Ruiz-Mafud, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante, R. Solís-Vivanco (Mexico City, Mexico)

COVID-19 impact on Anxiety, Depression, Stress, and Cortisol in Persons with Parkinson’s Disease

B. Lobb, A. Hiller (Portland, USA)

Depression and progression of motor symptoms in early stage of Parkinson’s disease

YS. Hwang, SJ. Chung (Seoul, Republic of Korea)

Determinants of symptom severity in Parkinson’s disease: the International Vacation Survey

J. Janssen Daalen, J. Hubbers, M. Sharifi Bonab, S. Mathur, D. Thijssen, B. Bloem, M. Meinders (Nijmegen, Netherlands)

DIFFERENCE IN MOTOR AND NONMOTOR SYMPTOMS BETWEEN YOUNG AND LATE ONSET PARKINSON`S DISEASE

LH. Horvat, Z. Popovic, T. Gilman Kuric, I. Rajkovaca Latic, T. Mirosevic Zubonja, J. Kragujevic, S. Tomic ()

DUtch PARkinson Cohort (DUPARC): Contrast Sensitivity and Retinal Changes in Early Parkinson’s Disease Patients

C. Gillen, S. Zee, N. Jansonius, T. van Laar (Groningen, Netherlands)

Effects of Subthalamic Nucleus Deep Brain Stimulation on pain in Parkinson disease: Real-life observational prospective study

I. Carvalho, D. Damas, I. Cunha, S. Caldeira, P. Monteiro, R. Pereira, F. Moreira (Coimbra, Portugal)

Evaluation of the anxiolytic effects of naringenin in rotenone-induced rat model of Parkinson’s disease by an elevated plus maze test

S. Madiha (Karachi, Pakistan)

Excessive tearing; a paradoxical ocular manifestation of Parkinson’s disease

S. Yaisawang, J. Sringean, N. Kasetsuwan, K. Pongpirol, R. Bhidayasiri (Bangkok, Thailand)

Factors that negatively impact the sexual function of men living with Parkinson’s disease

B. de Souza (São Paulo, Brazil)

Factors that negatively impact the sexual function of women living with Parkinson’s disease

K. Nobrega, R. Gonçalves, B. Silva, B. Souza, M. Piemonte (Macapa, Brazil)

Fatigue at different stages of parkinson’s disease

A. Tohirjonova, м. Tohirjonov (Tashkent, Uzbekistan)

Fear of progression is predicted by anxiety and self-efficacy but not disease-specific parameters in patients with Parkinson’s disease: data from a multicenter cross-sectional study

AK. Folkerts, L. Haarmann, J. Nielsen, J. Saliger, M. Eschweiler, H. Karbe, N. Allert, V. Vida, C. Trenkwalder, A. Kruse, H. Oelsner, G. Ebersbach, E. Kalbe (Cologne, Germany)

Gender-related sexual dysfunction in Parkinson disease: Clinical data of a hospital cohort in Tunisia

L. Ali, H. Jamoussi, N. Ben Ali, S. Fray, M. Ben Mahmoud, M. Fredj (Tunis, Tunisia)

Heart-brain synchronization breakdown in Parkinson’s disease

M. Iniguez, A. Jimenez-Marin, A. Erramuzpe, M. Acera, B. Tijero, A. Murueta-Goyena, R. Del Pino, T. Fernandez, M. Carmona‑abellan, A. Cabrera, JC. Gomez‑esteban, J. Cortes, I. Gabilondo (Getafe, Spain)

Imaging progressive peripheral and central dysfunction in isolated REM sleep behaviour disorder after 3 years of follow-up

T. Fedorova, K. Knudsen, K. Andersen, J. Horsager, C. Skjærbæk, M. Otto, K. Svendsen, P. Borghammer (Aarhus N, Denmark)

Impact of Nonmotor Symptoms on The Quality of Life of Parkinson’s Disease Patients

R. Nindela, O. Tambun, S. Marisdina, E. Bahar (Palembang, Indonesia)

Impact of SARS-CoV-2 vaccine in Parkinson’s disease

E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, P. Bazán-Rodríguez, MA. Ruiz-Mafud, AJ. Hernández-Medrano, GI. Cerda-Hernández, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

Influence of dopaminergig medication and subthalamic nucleus deep brain stimulation on impulsive decision making in Parkinson’s disease

JC. Baldermann, A. Nehs, H. Jergas, H. Dafsari, V. Visser-Vandewalle, T. Dembek, M. Barbe (Cologne, Germany)

Intestinal microbial dysbiosis promotes prebiotic-reversible inflammation in Parkinson’s disease

R. Manfready, D. Hall, C. Goetz, A. Keshavarzian (Chicago, USA)

Manifestations of Parkinson’s Disease in different ethnicities in Sumatera Indonesia: A Descriptive Study

S. Marisdina, S. Handayani, Y. Diansari, A. Afriani, R. Odiesta, M. Nur'Aini (Palembang, Indonesia)

Mindfulness based program for newly diagnosed Parkinson’s patients.

A. Shaji, A. Lasker, N. Ko, M. Solanki, P. Kaur, Y. Ocasio, C. Fanning (Bethlehem, USA)

Motor Fluctuations development is associated with non-motor symptoms burden progression in Parkinson´s disease patients. A 2-year follow-up study.

D. Santos, T. de Deus, C. Cores, M. Feal Painceiras, E. Suárez Castro, C. Martínez, S. Jesús, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, V. Puente, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Blázquez, M. Seijo, J. Ruíz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González, R. Alonso Redondo, C. Ordás, L. López Díaz, D. Mcafee, P. Martínez Martín, P. Mir, C. Coppadis (A Coruña, Spain)

Nocturnal Polyuria in Parkinson’s Disease

M. Smith, G. Portlock, A. Cullen, M. Drake, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

Non-motor fluctuations in People with Parkinson’s considering Deep Brain Stimulation surgery

T. Turner, F. Rodriguez-Porcel, C. Cooper, V. Hinson, G. Revuelta (Charleston, USA)

Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study

C. Liguori, C. de Masi, M. Spanetta, M. Fernandes, R. Cerroni, E. Garasto, M. Pierantozzi, N. Mercuri, A. Stefani (Rome, Italy)

Ocular ping pong movement to disentangle apathy from Bradykinesia in Parkinson’s disease

F. Rey, A. Zacharia, P. Krack, D. Benis, M. Bereau, R. Ptak, G. Allali, J. Bally (Geneva, Switzerland)

Outcomes of surgical management of pelvic floor dysfunction in women with Parkinson’s disease

D. Mohanty, A. Gupta, D. Sheyn, J. Gaskins, A. Mahajan (Louisville, USA)

Patients with Parkinson’s Disease Share a Unique Olfactory Perceptual Fingerprint

M. Andelman-Gur, K. Snitz, A. Ravia, N. Hezi, A. Ezra, D. Klepikov, T. Gurevich, N. Sobel (Rehovot, Israel)

Pattern of non-motor symptoms in Parkinson’s disease: A prospective observational study

S. Mudassir, A. Rai, A. Ranjan, A. Kumar (Patna, India)

Personalized Medicine: Assessing the Needs of People with Young-Onset Parkinson’s Disease

B. Mcdaniels, I. Subramanian, S. Kurian, S. Chitnis (Denton, USA)

POOR SLEEP QUALITY AND OBESITY IN PATIENTS WITH PARKINSON’S: PRELIMINARY RESULTS OF A COHORT STUDY

A. Ferrari Aquino, J. Garza Marichalar, D. Ortiz Zacarías, I. Estrada Bellmann, B. Chávez Luévanos (Monterrey, Mexico)

Predictors of loss to follow-up three years after inclusion in a prospective longitudinal cohort study in people with early Parkinson’s disease

C. Pauly, AM. Hanff, G. Aguayo, A. Rauschenberger, A. Leist, C. Mccrum, M. Zeegers, R. Krüger (Luxembourg, Luxembourg)

Predictors of relapse in impulse control disorders in patients with Parkinson’s disease.

L. Gaibor, D. Vazquez, H. Estrada (CDMX, Mexico)

Predictors of short-term anxiety outcome after subthalamic stimulation in Parkinson’s Disease

A. Sauerbier, V. Stopic, J. Herberg, P. Loehrer, K. Ashkan, A. Rizos, S. Jost, JN. Petry-Schmelzer, S. Heil, A. Gronostay, M. Barbe, V. Visser-Vandewalle, J. Evans, C. Nimsky, G. Fink, A. Antonini, P. Martinez-Martin, M. Silverdale, D. Weintraub, A. Schrag, K. Ray Chaudhuri, L. Timmermann, H. Dafsari (Cologne, Germany)

Preferences for discussing sexual health concerns

G. Bronner, S. Peleg Nesher, Y. Manor, A. Rosenberg, S. Naor, A. Ezra, R. Mallin, R. Hurvitz Alon, T. Gurevich (Tel Aviv, Israel)

Prevalence of sleep disorders in Parkinson’s disease patients at a Brazilian movement disorders center in 2022

L. Castanheira, C. Lobo, I. Oliveira, L. de Almeida, G. Valença (Salvador, Brazil)

Prevalence, clinical and neuropsychiatric aspects of Sleep Disorders in Parkinson’s disease: a meta-analysis

G. Maggi, F. Cerciello, I. Obeso, G. Santangelo (Caserta, Italy)

Psychometric characteristics of the Neuropsychiatric Fluctuation Scale

E. Schmitt, B. Debu, A. Kistner, A. Castrioto, V. Fraix, M. Bouvard, E. Moro (grenoble, France)

Quality of life changes after subthalamic stimulation for Parkinson’s disease depend on nonmotor and motor symptoms clusters

L. Braun, S. Jost, M. Silverdale, A. Rizos, M. Santos Ghilardi, R. Cury, P. Loehrer, C. Nimsky, K. Ashkan, A. Sauerbier, A. Gronostay, G. Fink, M. Barbe, J. Evans, V. Visser-Vandewalle, E. Fonoff, A. Antonini, L. Timmermann, P. Martinez-Martin, K. Chaudhuri, H. Dafsari (Cologne, Germany)

Quality of Life in African American and White Parkinson’s Disease Patients

D. Hall, S. Anderson, G. Stebbins, L. Barnes, M. Bailey, L. Shulman (Chicago, USA)

Relation of affective disorders and quality of life in the chronic pain of disease Parkinson’s patients

K. Stepanchenko, A. Jidkova (Kharkiv, Ukraine)

Relationship between brain bioelectrical activity during REM/NREM sleep, grey matter changes and visual disorders in patients with RBD in Parkinson’s disease

O. Alenikova, T. Svinkovskaya, N. Alenikov (Minsk, Belarus)

Retinal vascular change of Parkinson’s disease patients with orthostatic hypotension

JH. Ahn, D. Lee, JW. Cho, KA. Park, J. Youn (Seoul, Republic of Korea)

Sarcopenia Screening with Limb Circumference and Impacts of Sarcopenia in Parkinson’s disease

SJ. Kim, YJ. Jeong, SM. Cheon ()

Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative

Z. Meyer, C. Marras, A. Naito, N. Dahodwala, A. Ramirez-Zamora, M. Rose Rafferty, M. Neault, J. Beck, R. Deleon, T. Davis, S. Mantri, K. Mills, J. Miyasaki, E. Nelson, A. Brown, D. Weintraub, A. Allen (Miami, USA)

Sexual dysfunctions in Parkinson’s disease and their influence on partnership – data from the PRISM study

T. Kinateder, D. Marinho, L. Hatzler, D. Gruber, G. Ebersbach, F. Gandor (Beelitz-Heilstaetten, Germany)

sleep disturbance and wakefulness in parkinson’s disease

A. Tohirjonova, м. Tohirjonov (Tashkent, Uzbekistan)

Social Withdrawal in Parkinson’s Disease: A Scoping Review

S. Ahn, K. Springer, J. Gibson (Charlottesville, USA)

Socio-Clinical Factors Associated with Parkinson’s Disease Related Specific Self-Management Behaviors: The Role of Non-Motor Symptoms

M. Kafri, M. Abu Taieh, M. Duvdevani, I. Schlesinger, M. Nassar, I. Erich, R. Hadad, G. Yogev-Seligmann (Haifa, Israel)

Speech disorders and axial motor impairment in advanced Parkinson’s Disease: two sides of the same coin?

G. Di Rauso, C. Budriesi, F. Cavallieri, A. Gessani, S. Coniglio, V. Rispoli, F. Valzania, F. Antonelli (Modena, Italy)

Studying Care Patterns and Support Preferences Among People Living with Parkinson’s Disease

C. Pearson, M. Feeney, A. Willis, N. Yarab, R. Dolhun, V. Todaro, S. Rosenfeld (Chicago, USA)

Subjective Self-Report on Sexual Problems in Parkinson’s disease is Reliable

G. Bronner, S. Peleg Nesher, Y. Manor, A. Rosenberg, S. Naor, A. Ezra, N. Geriani, T. Gurevich (Tel Aviv, Israel)

Temporal dynamics and longitudinal predictors of apathy in Parkinson’s disease

C. Le Heron, M. Macaskill, K. Horne, L. Livingstone, T. Melzer, D. Myall, T. Pitcher, J. Dalrymple-Alford, T. Anderson, S. Harrison (Christchurch, New Zealand)

The Comparison of Constipation scoring system scales between Parkinson’s disease and non-Parkinson’s disease patients with constipation

K. Methawasin, A. Krittayasingh, P. Chonmaitree, M. Wongwandee, N. Kongsakorn (Nakhon Nayok, Thailand)

The cross-talk between microglia-derived exosomes and brain printing biometrics as a diagnostic approach for Parkinson’s disease prior to motor symptoms implications

M. Anwar, M. Fathi (Cairo, Egypt)

THE EFFECT OF DEEP BRAIN STIMULATION ON LOWER URINARY TRACT SYMPTOMS IN PARKINSON’S DISEASE

P. Araújo, A. Francisco, R. de Fraga, L. Frizon, M. ávila, I. Filho, L. Pancera, G. Schaidt, J. Goginski, A. Farinazzo (Curitiba, Brazil)

The impact of COVID-19 on Parkinson’s disease: a case-controlled registry and questionnaire study

G. Cedergren Weber, P. Odin, J. Timpka (Lund, Sweden)

The relationship of non-motor symptoms in Parkinson’s disease

E. Golchenko, Y. Karakulova (Perm, Russian Federation)

TWO-YEAR LONGITUDINAL FOLLOW-UP OF VISUAL ILLUSIONS AND HALLUCINATIONS IN PARKINSON’S DISEASE

S. Beze, L. Castellani, B. Pereira, F. Chiambaretta, F. Durif, A. Marques (Clermont-Ferrand, France)

Validation of a wireless Home-Based Sleep Laboratory for assessment of sleep-related disorders in Parkinson’s disease

S. Oz, A. Dagay, S. Katzav, D. Wasserman, E. Harduff, Y. Hanein, A. Mirelman (Tel Aviv, Israel)

Visual system abnormalities and visual hallucinations in Parkinson’s disease

M. Diez-Cirarda, A. Cabrera, A. Murueta-Goyena, A. Strafella, R. Del Pino, MA. Acera, O. Lucas-Jiménez, N. Ibarretxe-Bilbao, B. Tijero, JC. Gomez-Esteban, I. Gabilondo (Barakaldo, Spain)

Voluntary saccades slowness in parkinson disease and multiple system atrophy

JY. Yoon, CY. Lee, HJ. Kim, SH. Kim (Seoul, Republic of Korea)

What is the appropriate sleep position for Parkinson’s disease patients with orthostatic hypotension in the morning?

T. Prasertpan, R. Chokesuwattanaskul, J. Sringean, S. Siwanogsatham, R. Bhidayasiri (Bangkok, Thailand)

What, when and how should the information on iRBD and risk of Parkinson’s disease and related conditions be communicated?

H. Chohan, C. Simonet, A. Gill, A. Schrag, A. Noyce, L. Pérez-Carbonell (London, United Kingdom)